| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Multiple sclerosis | 607 | 103 | |
| Chronic lymphocytic leukemia | 18 | 0 | |
| T-cell prolymphocytic leukemia | 10 | 1 | |
| Participate in clinical trial | 3 | 2 | |
| Bone marrow transplant | 1 | 1 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Headaches | 17 | |
| Fatigue | 16 | |
| Fever/chills | 7 | |
| Generalized weakness (asthenia) | 5 | |
| Hives (urticaria) | 5 | |
| Nausea | 4 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 8 | |
| Moderate | 24 | |
| Mild | 37 | |
| None | 39 |
Member evaluations
GPS
evaluated on Jan 28, 2009
- Perceived effectiveness for multiple sclerosis: Major
- Side effects: Moderate